Skip to main content
Signal8

Reich Kristian

SEC insider (Form 3/4/5 filer). CIK 0001920553. Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX). 19 reported Form 4/5 transactions since Sep 2024; latest on Jul 27, 2026. Located in ZUG.

Companies Reich Kristian has filed insider reports for

  • MoonLake Immunotherapeutics (MLTX): Officer, Chief Scientific Officer
Reich Kristian profile photo

Reich Kristian

CIK: 0001920553

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)10 (52.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (10.5%)

Compensation grants

Other (G, F, J, C, D, …)7 (36.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MoonLake Immunotherapeutics logo
MLTX

MoonLake Immunotherapeutics

Officer

Discretionary Trading P&L

Holdings

Transaction History (19 total)

  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jul 27, 2026
    Sale
    Indirect
    1.1K shares at avg. $20.00$22K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jul 22, 2026
    Sale
    Indirect
    2.4K shares at avg. $20.00$49K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jul 21, 2026
    Sale
    Indirect
    50K shares at avg. $20.02$1.0M
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jul 20, 2026
    Sale
    Indirect
    43.7K shares at avg. $20.09$878K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jul 15, 2026
    Sale
    Indirect
    16.1K shares at avg. $20.01$322K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jun 17, 2026
    Sale
    Indirect
    50K shares at avg. $19.43$972K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jun 16, 2026
    Sale
    Indirect
    50K shares at avg. $18.70$935K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jun 15, 2026
    Sale
    Indirect
    50K shares at avg. $18.89$945K
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Jan 7, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    520.3K shares-
  • MoonLake Immunotherapeutics logo
    MLTX

    MoonLake Immunotherapeutics

    Dec 19, 2025
    Disposition
    Direct
    35.4K shares-

1-10 of 19